Treating to the target of remission in early rheumatoid arthritis is cost-effective: results of the DREAM registry.
SourceBMC Musculoskeletal Disorders, 14, 1, (2013), pp. 350
Article / Letter to editor
Display more detailsDisplay less details
BMC Musculoskeletal Disorders
SubjectIGMD 2: Molecular gastro-enterology and hepatology; NCEBP 2: Evaluation of complex medical interventions N4i 4: Auto-immunity, transplantation and immunotherapy
Upload full text
Use your RU credentials (u/z-number and password) to log in with SURFconext to upload a file for processing by the repository team.